Bernstein Liebhard LLP Announces Investigation on Behalf of Shareholders of Genzyme Corporation

Published on Tuesday, 31 August 2010 12:36 Written by TradersHuddle Staff

NEW YORK-( Business Wire )-

Bernstein Liebhard LLP is investigating whether the Board of Directors of Genzyme Corporation (“Genzyme” or the “Company”) (Nasdaq: GENZ) is breaching its fiduciary duty to the Company’s shareholders by not agreeing to sell Genzyme to Sanofi-Aventis and/or not seeking to maximize value for the Company’s shareholders.

If you are interested in discussing your rights as a Genzyme shareholder and/or have information relating to the matter, please contact U. Seth Ottensoser at (877) 779-1414 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it. .

Bernstein Liebhard has pursued hundreds of securities, consumer and shareholder rights cases and recovered almost $3 billion for its clients. It has been named to The National Law Journal’s “Plaintiffs’ Hot List” in each of the last seven years.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

(877) 779-1414

www.bernlieb.com

ATTORNEY ADVERTISING. © 2010 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Bernstein Liebhard LLPU. Seth Ottensoser, This e-mail address is being protected from spambots. You need JavaScript enabled to view it.